Raymond James & Associates’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,535
Closed -$489K 3784
2018
Q3
$489K Sell
10,535
-12,657
-55% -$612K ﹤0.01% 2721
2018
Q2
$1.12M Buy
23,192
+1,001
+5% +$47.9K ﹤0.01% 2120
2018
Q1
$961K Buy
22,191
+25
+0.1% +$1.12K ﹤0.01% 2156
2017
Q4
$880K Sell
22,166
-918
-4% -$38.3K ﹤0.01% 2198
2017
Q3
$1M Sell
23,084
-595
-3% -$27.2K ﹤0.01% 2093
2017
Q2
$1.13M Buy
23,679
+4,974
+27% +$232K ﹤0.01% 1952
2017
Q1
$768K Buy
18,705
+4,254
+29% +$178K ﹤0.01% 2129
2016
Q4
$555K Buy
14,451
+6,443
+80% +$262K ﹤0.01% 2275
2016
Q3
$430K Buy
8,008
+1,587
+25% +$73.7K ﹤0.01% 2384
2016
Q2
$276K Buy
6,421
+197
+3% +$8.27K ﹤0.01% 2464
2016
Q1
$314K Buy
+6,224
New +$299K ﹤0.01% 2303

Other funds holding IMPV

Raymond James & Associates's IMPV Position: Q4 2018 in Review

Raymond James & Associates sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 10,535 shares — an estimated $489K sold.

Raymond James & Associates first reported a position in IMPV in Q1 2016 and held it in 11 quarters. The position peaked at $1.13M in Q2 2017. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

  • Raymond James & Associates reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
  • Raymond James & Associates sold 10,535 Imperva, Inc. shares in Q4 2018, an estimated $489K.
  • Raymond James & Associates first reported a position in Imperva, Inc. in Q1 2016 and held it in 11 quarters.
  • Raymond James & Associates's Imperva, Inc. position peaked at $1.13M in Q2 2017.
  • 162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.